obesity
9 articles tagged with ‘obesity’
Retatrutide in Canada: Access, Trials, and Approval Timing
Retatrutide is not yet approved in Canada; access is limited to clinical trials. This article outlines the current status, evidence, and realistic timelines for availability.
MOTS-C and Metabolism: How Does MOTS-C Improve Endurance and Bone Strength?
Explore the preclinical science behind MOTS-C, a mitochondrial peptide investigated for its effects on metabolism, endurance, and bone strength.
Tesofensine: Triple Monoamine Reuptake Inhibitor in Metabolic Research
Tesofensine triple monoamine reuptake inhibitor metabolic research preclinical evidence mechanisms safety
5-Amino-1MQ: NAD+ Salvage Pathway and Metabolic Research — A Scientific Review
Explore 5-Amino-1MQ research: NAD+ salvage pathway, NNMT inhibition, and metabolic effects in preclinical models.
What Is Retatrutide? Triple-Agonist Peptide Research Overview
Triple-agonist retatrutide research overview: mechanism, preclinical findings, evidence limitations, and safety considerations for laboratory investigation.
Cagrilintide Research: What Is Cagrilintide and How Does It Work?
Research review of Cagrilintide, a dual amylin and calcitonin receptor agonist, covering mechanism, preclinical data, and safety.
Melanotan 2 and Appetite: Research on Hunger Suppression via MC4R Activation
Explore the research on Melanotan 2 and appetite suppression via MC4R activation. Preclinical evidence, mechanisms, and limitations reviewed.
NAD+ and Glutathione: Anti-Aging Research, Benefits, and Synergistic Potential
Explore NAD+ and glutathione synergy in anti-aging research, mechanisms, preclinical evidence, and safety considerations for laboratory study.
Harnessing Peptides for Metabolic Health: Advances in Diabetes and Obesity Research
Explore the research potential of peptides for metabolic health, including diabetes and obesity. A review of preclinical evidence and safety.